Washington, DC (PRWEB) July 11, 2012
Taking place at the Omni Shoreham Hotel in Washington, DC and hosted by the Mesothelioma Applied Research Foundation (Meso Foundation), the 2012 Symposium brings together mesothelioma researchers, doctors, medical professionals, mesothelioma patients and their families, and other advocates while featuring research progress, discussing treatment options, and raising awareness of mesothelioma.
At the 2012 Symposium, the Meso Foundation is proud to feature presenters such as Raja Flores, MD, Giovanni Gaudino, PhD, Steven Hahn, MD, Harvey Pass, MD, Daniel Sterman, MD, David Sugarbaker, MD, Raffit Hassan, MD, Robert Kratzke, MD, Lee Krug, MD, and many others.
The two-day program is made possible by the generous support and educational grants from the following: Levy Phillips & Konigsberg, LLP; The Law Offices of Peter G. Angelos; Early, Lucarelli, Sweeney, Strauss; Kazan, McClain, Lyons, Greenwood & Harley; MotleyRice, LLC, Simmons Firm; The International Association of Heat and Frost Insulators and Allied Workers; Lilly USA, LLC; Gori Julian & Associates, P.C.; Shrader & Associates; James F. Humphreys & Associates L.C., & Pinnacle Biologics.
Mesothelioma, a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos is considered one of the most aggressive of all cancers. Approximately 3,000 Americans are diagnosed with mesothelioma every year, yet the very few available treatments have limited effectiveness.
ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the leading organization dedicated to eradicating mesothelioma and easing the suffering caused by it. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research and increased awareness. The Foundation is the only organization that funds peer-reviewed research solely for mesothelioma to help find effective treatment options and a cure for the 3,000 Americans diagnosed each year. To date, the Foundation has awarded $7.6 million to research.
More information and donation forms are available at http://www.curemeso.org.